Quotes 5-day view Delayed Nasdaq
08/01/2022
08/02/2022
08/03/2022
08/04/2022
08/05/2022
Date
2.92(c)
3.1(c)
3.08(c)
2.97(c)
3.26(c)
Last
6 209 483
9 283 311
7 410 965
6 833 507
10 441 706
Volume
+4.29%
+6.16%
-0.65%
-3.57%
+9.76%
Change
Estimated financial data (e) (USD)
Sales 2022
3 306 M
-
-
Net income 2022
-361 M
-
-
Net cash position 2022
108 M
-
-
P/E ratio 2022
-4,16x
Yield 2022
-
Sales 2023
4 190 M
-
-
Net income 2023
-292 M
-
-
Net cash position 2023
305 M
-
-
P/E ratio 2023
-5,29x
Yield 2023
-
Capitalization
1 535 M
1 535 M
-
EV / Sales 2022
0,43x
EV / Sales 2023
0,29x
Nbr of Employees
680
Free-Float
69,9%
Clover Health Investments, Corp. is a healthcare technology company. The Company’s segments include Medicare Advantage (MA) and Direct Contracting (DC). The MA segment is an insurance business model that focuses on leveraging the Clover Assistant at the point of care. The Company’s DC segment is similar to the cost management and care coordination model accounted for as a performance guarantee, where Clover is...
Ratings of Clover Health Investments, Corp.
All news about CLOVER HEALTH INVESTMENTS, CORP.
News in other languages on CLOVER HEALTH INVESTMENTS, CORP.
Analyst Recommendations on CLOVER HEALTH INVESTMENTS, CORP.
Palihapitiya says SPAC slowdown separated 'wheat from chaff'
Chart CLOVER HEALTH INVESTMENTS, CORP.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CLOVER HEALTH INVESTMENTS, CORP.
Short Term Mid-Term Long Term Trends Bullish Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
3,26 $
Average target price
3,58 $
Spread / Average Target
9,92%
Please enable JavaScript in your browser's settings to use dynamic charts.